14 results on '"Mackern-Oberti, Juan P."'
Search Results
2. Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus
- Author
-
Mackern-Oberti, Juan P., Llanos, Carolina, Riedel, Claudia A., Bueno, Susan M., and Kalergis, Alexis M.
- Published
- 2015
- Full Text
- View/download PDF
3. Carbon monoxide exposure improves immune function in lupus-prone mice
- Author
-
Mackern-Oberti, Juan P., Llanos, Carolina, Carreño, Leandro J., Riquelme, Sebastián A., Jacobelli, Sergio H., Anegon, Ignacio, and Kalergis, Alexis M.
- Published
- 2013
- Full Text
- View/download PDF
4. Haem oxygenase 1 expression is altered in monocytes from patients with systemic lupus erythematosus
- Author
-
Herrada, Andrés A., Llanos, Carolina, Mackern-Oberti, Juan P., Carreño, Leandro J., Henriquez, Carla, Gómez, Roberto S., Gutierrez, Miguel A., Anegon, Ignacio, Jacobelli, Sergio H., and Kalergis, Alexis M.
- Published
- 2012
- Full Text
- View/download PDF
5. Tolerogenic dendritic cell transfer ameliorates systemic lupus erythematosus in mice.
- Author
-
Funes, Samanta C., Ríos, Mariana, Gómez‐Santander, Felipe, Fernández‐Fierro, Ayleen, Altamirano‐Lagos, María J., Rivera‐Perez, Daniela, Pulgar‐Sepúlveda, Raul, Jara, Evelyn L., Rebolledo‐Zelada, Diego, Villarroel, Alejandra, Roa, Juan C., Mackern‐Oberti, Juan P., and Kalergis, Alexis M.
- Subjects
SYSTEMIC lupus erythematosus ,DENDRITIC cells ,SUPPRESSOR cells ,AUTOIMMUNE disease treatment ,MICE ,NEPHRITIS - Abstract
Summary: Current treatments for systemic autoimmune diseases partially improve the health of patients displaying low pharmacological efficacy and systemic immunosuppression. Here, the therapeutic potential of transferring tolerogenic dendritic cells (tolDCs) generated with heme‐oxygenase inductor cobalt (III) protoporphyrin IX (CoPP), dexamethasone and rosiglitazone for the treatment of systemic autoimmunity was evaluated in two murine models of systemic lupus erythematosus (SLE), MRL‐Faslpr and NZM2410 mice. Dendritic cells treated ex vivo with these drugs showed a stable tolerogenic profile after lipopolysaccharide stimulation. Regular doses of tolDCs were administered to anti‐nuclear antibody‐positive mice throughout 60–70 days, and the clinical score was evaluated. Long‐term treatment with these tolDCs was well tolerated and effective to improve the clinical score on MRL‐Faslpr lupus‐prone mice. Additionally, decreased levels of anti‐nuclear antibodies in NZM2410 mice were observed. Although tolDC treatment increased regulatory T cells, no significant reduction of renal damage or glomerulonephritis could be found. In conclusion, these results suggest that the transfer of histone‐loaded tolDCs could improve only some SLE symptoms and reduced anti‐nuclear antibodies. This is the first study to evaluate antigen‐specific tolDC administration to treat SLE. Our report strengthens the clinical relevance of tolDC generation with CoPP, dexamethasone and rosiglitazone and the use of these modified cells as a therapy for systemic autoimmunity. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
6. Leishmaniasis in the Argentine Republic: Temporal and geographical distribution from 2013 to 2017.
- Author
-
Germano, María, Salomón, María, Neira, Gisela, Lozano, Esteban, Mackern-Oberti, Juan, and Cargnelutti, Diego
- Abstract
Objective: To assess the temporal and geographical distribution of confirmed cases of cutaneous, mucocutaneous and visceral leishmaniasis in the Argentine Republic from 2013 to 2017. Methods: A retrospective study was carried out using data collected from the Integrated Surveillance Bulletin database of the National System of Health Surveillance. Confirmed cases of cutaneous, mucocutaneous and visceral leishmaniasis up to the 52nd epidemiological week of each year was included. Results: In the 5 years period, 1 295 confirmed leishmaniasis cases were reported in the Argentine Republic. One thousand twenty-eight (1 028) cases corresponded to cutaneous leishmaniasis (87.10%), being the most common type of leishmaniasis. Mucocutaneous leishmaniasis was in the second place in the country with 115 cases reported, mostly in the Northwest and Northeast regions. A total of 52 individuals with visceral leishmaniasis were identified and Misiones Province was the most affected. Conclusions: It is important to analyze the temporal and geographical distribution of leishmaniasis in order to provide an adequate management and surveillance. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
7. Chronic Infection of the Prostate by Chlamydia muridarum Is Accompanied by Local Inflammation and Pelvic Pain Development.
- Author
-
Sanchez, Leonardo R., Breser, Maria L., Godoy, Gloria J., Salazar, Florencia C., Mackern‐Oberti, Juan P., Cuffini, Cecilia, Motrich, Ruben D., and Rivero, Virginia E.
- Published
- 2017
- Full Text
- View/download PDF
8. Male Rat Genital Tract Infection With Chlamydia Muridarum has No Significant Consequence on Male Fertility.
- Author
-
Motrich, Ruben Darío, Sanchez, Leonardo, Maccioni, Mariana, Mackern-Oberti, Juan Pablo, and Rivero, Virginia Elena
- Subjects
MALE reproductive organ diseases ,CHLAMYDIA trachomatis ,LABORATORY rats ,ANIMAL infertility ,POLYMERASE chain reaction ,SEMEN ,APOPTOSIS - Abstract
Purpose: Chlamydia trachomatis infection of the male genital tract was proposed to alter male fertility. We studied the putative consequences of chlamydial male genital tract infection on semen quality and male fertility in an experimental rat model of infection. Materials and Methods: We used 36 male and 40 female Wistar rats. Male genital infection was created by inoculating Chlamydia muridarum in the meatal urethra. The presence of C. muridarum was evaluated by polymerase chain reaction in semen and male genital tract organs early (15 days) and late (80 days) after infection. Sperm quality parameters were assayed in seminal and epididymal sperm from sham infected and infected rats. Mating studies with sexually mature females were performed and fertility parameters were assayed, including potency, fecundity and fertility indexes, fetal size, and pre-implantation and post-implantation embryo loss. Results: Male rats showed ascending, disseminated infection 15 days after infection. Bacteria persisted in the prostate and seminal vesicles 80 days after infection. C. muridarum was detected in semen in most rats regardless of acute or chronic infection. Seminal or epididymal sperm quality did not differ in infected and sham infected rats 15 or 80 days after infection. Sperm apoptosis was also minimal in infected rats. No differences were observed in fertility parameters between infected and sham infected rats. Conclusions: C. muridarum infects the rat male genital tract and persists mainly in the prostate. Although C. muridarum was detected in semen during acute and chronic infection, no alterations in sperm quality were observed. C. muridarum infection does not impair male fertility. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
9. Male Rodent Genital Tract Infection With Chlamydia Muridarum: Persistence in the Prostate Gland That Triggers Self-Immune Reactions in Genetically Susceptible Hosts.
- Author
-
Mackern-Oberti, Juan Pablo, Motrich, Ruben Dario, Breser, Maria Laura, Cejas, Hugo, Cuffini, Cecilia, Maccioni, Mariana, and Rivero, Virginia Elena
- Subjects
GENITAL diseases ,CHLAMYDIA trachomatis ,ENZYME-linked immunosorbent assay ,MEMBRANE proteins ,IMMUNE response ,AUTOIMMUNITY ,LABORATORY rodents ,PROSTATE diseases - Abstract
Purpose: We investigated Chlamydia trachomatis infection and its pathogenic consequences in the male rodent genital tract. Materials and Methods: Male rats were inoculated in the meatal urethra with Chlamydia muridarum. We sought bacterial DNA at early and late times after inoculation in different parts of the male genital tract. Histological alterations and the immune response against prostate antigens were analyzed. Results: Male rats showed ascending infection with wide dissemination of bacteria in the genital tract at an early time point after inoculation. At later stages bacteria persisted only in some parts of the genital tract and in the prostate gland. C. muridarum was also detected in semen in a high proportion of rats irrespective of an acute or chronic stage of infection. Histological alterations that accompanied C. muridarum were especially observed in the prostate and mainly composed of CD3+ cell infiltration. Positive humoral and cellular responses against prostate antigens were noted in a considerable number of infected rats. NOD mice, an autoimmune, prostatitis prone strain, showed a similar pattern with C. muridarum in the prostate of 100% of infected mice, which was again accompanied by mononuclear cell infiltration and antibodies against prostate antigens at early and late times after inoculation. Conclusions: Results reveal that C. muridarum infects the male rodent genitourinary tract with special persistence in the prostate gland, where it causes chronic inflammation that in turn may act as a trigger factor for self-immune reactions in susceptible hosts. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
10. Contribution of Dysregulated DNA Methylation to Autoimmunity.
- Author
-
Funes, Samanta C., Fernández-Fierro, Ayleen, Rebolledo-Zelada, Diego, Mackern-Oberti, Juan P., and Kalergis, Alexis M.
- Subjects
DNA methylation ,SYSTEMIC lupus erythematosus ,THERAPEUTICS ,AUTOIMMUNITY ,T cells ,AUTOIMMUNE diseases ,EPIGENOMICS - Abstract
Epigenetic mechanisms, such as DNA methylation, histone modifications, and non-coding RNAs are known regulators of gene expression and genomic stability in cell growth, development, and differentiation. Because epigenetic mechanisms can regulate several immune system elements, epigenetic alterations have been found in several autoimmune diseases. The purpose of this review is to discuss the epigenetic modifications, mainly DNA methylation, involved in autoimmune diseases in which T cells play a significant role. For example, Rheumatoid Arthritis and Systemic Lupus Erythematosus display differential gene methylation, mostly hypomethylated 5′-C-phosphate-G-3′ (CpG) sites that may associate with disease activity. However, a clear association between DNA methylation, gene expression, and disease pathogenesis must be demonstrated. A better understanding of the impact of epigenetic modifications on the onset of autoimmunity will contribute to the design of novel therapeutic approaches for these diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Chlamydia trachomatis occurrence and its impact on sperm quality in chronic prostatitis patients.
- Author
-
Motrich, Rubén Darío, Cuffini, Cecilia, Mackern Oberti, Juan Pablo, Maccioni, Mariana, and Rivero, Virginia Elena
- Subjects
CHLAMYDIA trachomatis ,SPERMATOZOA ,IMMUNOGLOBULINS ,TESTIS - Abstract
Summary: Objectives: The role of Chlamydia trachomatis (CT) in the pathogenesis of chronic prostatitis and its impact on male fertility remain controversial. The aim of this study was to assess the occurrence of chlamydial infection in chronic prostatitis patients and its impact on semen quality. Methods: Urine and semen samples were assayed for the presence of microbial infection. CT-specific IgG and IgA antibodies were measured in serum and seminal plasma. Semen parameter analysis, anti-sperm antibody determinations and inflammatory cytokines measurements were performed. Results: CT was detected in 10% of semen from chronic prostatitis patients. CT-specific IgG and IgA were found in 7.5% and 32.5% of the seminal plasma and in 15.0% and 2.5% of the serum samples from patients. Most of the patients that evidenced CT infection also evidenced CT-specific antibodies either in semen or in serum. We found that chlamydial infection has no detrimental effects on sperm quality. We neither found abnormal levels of serum PSA nor of seminal inflammatory cytokines in CT-infected patients. Conclusions: Our results support the potential role of CT in chronic prostatitis, its importance in diagnosis and that this infection does not seriously compromise sperm quality. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
12. Implications of prostate inflammation on male fertility.
- Author
-
Motrich, Ruben D., Salazar, Florencia C., Breser, Maria L., Mackern‐Oberti, Juan P., Godoy, Gloria J., Olivera, Carolina, Paira, Daniela A., and Rivero, Virginia E.
- Subjects
PROSTATE ,HUMAN fertility ,INFLAMMATION ,EXOCRINE glands ,MAMMAL fertility - Abstract
The prostate is the seat of three major causes of morbidity: benign prostatic hyperplasia, prostate cancer and prostatitis, three conditions in which inflammation has been implicated. A state of inflammation of the prostate gland, originally incited by an infection, an autoimmune response, a neurogenic stimulus or another trigger may have consequences on prostate functionality. In fact, male fertility depends intrinsically on the content of prostatic fluid factors secreted by the prostatic epithelium. Taking into account that the prostate gland is the major male accessory gland that exerts essential functions for male fertility, a state of local inflammation can alter male fertility by either directly impairing sperm quality or, indirectly, by causing prostate dysfunction. In the present review, we summarise the current knowledge regarding prostatitis due to well‐known infections such as Escherichia coli, Chlamydia trachomatis and other commonly identified microorganisms focusing on inflammatory markers detected during these infections and seminal quality and male fertility alterations reported. We also focused on type III prostatitis or chronic nonbacterial prostatitis/chronic pelvic pain syndrome, of unknown aetiology, in which inflammation of an autoimmune origin, neurogenic stimuli or another trigger have been proposed and fertility alterations reported. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
13. Immune checkpoints and the regulation of tolerogenicity in dendritic cells: Implications for autoimmunity and immunotherapy.
- Author
-
Funes, Samanta C., Manrique de Lara, Amaranta, Altamirano-Lagos, María J., Mackern-Oberti, Juan P., Escobar-Vera, Jorge, and Kalergis, Alexis M.
- Subjects
- *
DENDRITIC cells , *AUTOIMMUNITY , *GRAFT rejection , *IMMUNOLOGICAL tolerance , *IMMUNE system - Abstract
The immune system is responsible for defending the host from a large variety of potential pathogens, while simultaneously avoiding immune reactivity towards self-components. Self-tolerance has to be tightly maintained throughout several central and peripheral processes; immune checkpoints are imperative for regulating the immunity/tolerance balance. Dendritic cells (DCs) are specialized cells that capture antigens, and either activate or inhibit antigen-specific T cells. Therefore, they play a key role at inducing and maintaining immune tolerance. DCs that suppress the immune response have been called tolerogenic dendritic cells (tolDCs). Given their potential as a therapy to prevent transplant rejection and autoimmune damage, several strategies are under development to generate tolDCs, in order to avoid activation and expansion of self-reactive T cells. In this article, we summarize the current knowledge relative to the main features of tolDCs, their mechanisms of action and their therapeutic use for autoimmune diseases. Based on the literature reviewed, autologous antigen-specific tolDCs might constitute a promising strategy to suppress autoreactive T cells and reduce detrimental inflammatory processes. • Tolerogenic dendritic cells exhibit a stable immature or semi-mature phenotype. • Generation of tolerogenic dendritic cells is associated to inhibitory checkpoint molecules expression. • Therapeutic administration of tolerogenic dendritic cells loaded with disease-relevant antigens induces specific tolerance. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
14. Expression of CXCR3 on Specific T Cells Is Essential for Homing to the Prostate Gland in an Experimental Model of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
- Author
-
Breser, Maria L., Motrich, Ruben D., Sanchez, Leonardo R., Mackern-Oberti, Juan P., and Rivero, Virginia E.
- Subjects
- *
PROSTATITIS , *PELVIC pain , *PROSTATE , *T cells , *CHEMOKINE receptors , *INTERFERON gamma , *IMMUNOREGULATION - Abstract
Experimental autoimmune prostatitis (EAP) is considered a valid model for the human disease chronic prostatitis/chronic pelvic pain syndrome. In this report, we analyzed phenotypic characteristics of T cells that gain access to the prostate and induce leukocyte recruitment in mice with different susceptibility to EAP. After EAP induction, NOD mice developed a specific cellular response characterized by a mixed Th1/Th17 pattern with specific T cells mainly expressing CXCR3 that infiltrated and damaged the prostate. In contrast, BALB/c mice, as well as NOD-IFN-γ-/-, exhibited only Th17 cells mainly expressing CCR6 that were not capable of infiltrating the prostate gland. Adoptive transfer experiments of T cells from NOD or NOD-IFN-γ-/- mice to NOD-SCID recipients showed that only T cells from NOD mice successfully infiltrated the prostate. However, after "in vitro" or "in vivo" treatment with rIFN-γ, T cells from NOD-IFN-γ-/- mice became capable of homing to the prostate and induced leukocyte recruitment. Chemokine levels in prostate tissue from NOD mice showed increased expression levels of CXCR3 ligands. Additional experiments using adoptive transfer of sorted CXCR3+CD3+ T cells or administrating a CXCR3 antagonist treatment confirmed these previous results. Altogether, our results demonstrate that the expression of CXCR3 on effector T cells is essential for their homing to the prostate gland in EAP. CXCR3 emerges as a potential therapeutic target to control chronic prostatitis/chronic pelvic pain syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.